{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:34:28Z","timestamp":1794558868762,"version":"4.9.1"},"reference-count":613,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:p>\n            Discovered in 1987 as a potent endothelial cell\u2013derived vasoconstrictor peptide, endothelin-1 (ET-1), the predominant member of the endothelin peptide family, is now recognized as a multifunctional peptide with cytokine-like activity contributing to almost all aspects of physiology and cell function. More than 30\u2009000 scientific articles on endothelin were published over the past 3 decades, leading to the development and subsequent regulatory approval of a new class of therapeutics\u2014the endothelin receptor antagonists (ERAs). This article reviews the history of the discovery of endothelin and its role in genetics, physiology, and disease. Here, we summarize the main clinical trials using ERAs and discuss the role of endothelin in cardiovascular diseases such as arterial hypertension, preecclampsia, coronary atherosclerosis, myocardial infarction in the absence of obstructive coronary artery disease (MINOCA) caused by spontaneous coronary artery dissection (SCAD), Takotsubo syndrome, and heart failure. We also discuss how endothelins contributes to diabetic kidney disease and focal segmental glomerulosclerosis, pulmonary arterial hypertension, as well as cancer, immune disorders, and allograft rejection (which all involve ET\n            <jats:sub>A<\/jats:sub>\n            autoantibodies), and neurological diseases. The application of ERAs, dual endothelin receptor\/angiotensin receptor antagonists (DARAs), selective ET\n            <jats:sub>B<\/jats:sub>\n            agonists, novel biologics such as receptor-targeting antibodies, or immunization against ET\n            <jats:sub>A<\/jats:sub>\n            receptors holds the potential to slow the progression or even reverse chronic noncommunicable diseases. Future clinical studies will show whether targeting endothelin receptors can prevent or reduce disability from disease and improve clinical outcome, quality of life, and survival in patients.\n          <\/jats:p>","DOI":"10.1161\/hypertensionaha.119.12105","type":"journal-article","created":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T10:00:40Z","timestamp":1572861640000},"page":"1232-1265","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":259,"title":["Endothelin: 30 Years From Discovery to Therapy"],"prefix":"10.1161","volume":"74","author":[{"given":"Matthias","family":"Barton","sequence":"first","affiliation":[{"name":"From Molecular Internal Medicine, University of Z\u00fcrich, Switzerland (M.B.)"},{"name":"Andreas Gr\u00fcntzig Foundation, Z\u00fcrich, Switzerland (M.B.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Yanagisawa","sequence":"additional","affiliation":[{"name":"International Institute for Integrative Sleep Medicine (WPI-IIIS) and Life Science Center, Tsukuba Advanced Research Alliance, University of Tsukuba, Japan (M.Y.)"},{"name":"Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX (M.Y.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/288373a0"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/460047a"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.53.5.557"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.3.9.2545495"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.84.24.9265"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2011.02.013"},{"key":"e_1_3_4_8_2","first-page":"325","article-title":"Contribution of the endothelium to the response to anoxia in the canine femoral artery.","volume":"253","author":"De Mey JG","year":"1981","unstructured":"De Mey, JG, Vanhoutte, PM. Contribution of the endothelium to the response to anoxia in the canine femoral artery. Arch Int Pharmacodyn Ther. 1981;253:325\u2013326.","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.51.4.439"},{"key":"e_1_3_4_10_2","first-page":"899","article-title":"Characterization of a potent coronary vasoconstrictor produced by endothelial cells in culture.","volume":"43","author":"Agricola K","year":"1984","unstructured":"Agricola, K, Rubanyi, GM, Paul, RJ, Highsmith, RF. Characterization of a potent coronary vasoconstrictor produced by endothelial cells in culture. Fed Proc. 1984;43:899.","journal-title":"Fed Proc"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1985.sp015728"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.1985.248.5.C550"},{"key":"e_1_3_4_13_2","first-page":"339","article-title":"Sustained coronary vasoconstriction provoked by a peptidergic substance released from endothelial cells in culture.","volume":"236","author":"Gillespie MN","year":"1986","unstructured":"Gillespie, MN, Owasoyo, JO, McMurtry, IF, O\u2019Brien, RF. Sustained coronary vasoconstriction provoked by a peptidergic substance released from endothelial cells in culture. J Pharmacol Exp Ther. 1986;236:339\u2013343.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.1041320210"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2014.09.001"},{"key":"e_1_3_4_16_2","volume-title":"The Thirteenth International Conference on Endothelin, University of Tsukuba","author":"Yanagisawa M","unstructured":"Yanagisawa, M. How to Identify a mysterious constricting factor, 1980s brute force biochemistry, and a NO-bel Prize - a conversation between Julia Straube and Masashi Yanagisawa. The Thirteenth International Conference on Endothelin, University of Tsukuba, Toyko Campus, Tokyo, Japan, September 8-11, 2013. https:\/\/vimeo.com\/95723638"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2010.08.004"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2012.07.002"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0008-6363(98)00153-9"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2012.07.017"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/332411a0"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17571-5"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/348673a0"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1139\/Y08-059"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1124\/pr.115.011833"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.8.2863"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)63739-1"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1006\/geno.1999.6083"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/335303b0"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2845579"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxicon.2011.03.002"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfs001"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1107\/S2053230X18016011"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1107\/S2053230X18018101"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI66735"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2012.05.010"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2011.01786.x"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(90)80583-5"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.41.1.851"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05365-2"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.001624"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40560-017-0219-y"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2014.09.009"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2014.09.027"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI7447"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(92)90252-e"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.fjc.0000166219.65593.af"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.112.202275"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI9997"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.131147598"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2016.03.018"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2015.02.001"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2008.06.007"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0704384"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1038\/348732a0"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1038\/348730a0"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291x(91)90158-4"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)54515-4"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature19319"},{"key":"e_1_3_4_60_2","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb.3450"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07094-0"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaw5188"},{"key":"e_1_3_4_63_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.12.8664"},{"key":"e_1_3_4_64_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.102.19.2434"},{"key":"e_1_3_4_65_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.85.24.9797"},{"key":"e_1_3_4_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291x(89)92648-x"},{"key":"e_1_3_4_67_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200018030-00006"},{"key":"e_1_3_4_68_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.94.7.1578"},{"key":"e_1_3_4_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291x(92)90683-c"},{"key":"e_1_3_4_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(92)90331-i"},{"key":"e_1_3_4_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2016.02.069"},{"key":"e_1_3_4_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2019.03.004"},{"key":"e_1_3_4_73_2","doi-asserted-by":"publisher","DOI":"10.1038\/365759a0"},{"key":"e_1_3_4_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2014.08.011"},{"key":"e_1_3_4_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(95)91504-4"},{"key":"e_1_3_4_76_2","volume-title":"Meeting Abstract Book 10th International Conference on Endothelin","author":"Green S","unstructured":"Green, S, Bundey, RA, Nunley, K, Hartman, JC, Melvin, LS, Gorczynski, RJ, Insel, PA, Bristow, MR, Pitts, KR. Determination of endothelin receptor antagonist affinities and selectivities in human cardiac membranes. 2007. Meeting Abstract Book 10th International Conference on Endothelin, Bergamo September 2007."},{"key":"e_1_3_4_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06250-X"},{"key":"e_1_3_4_78_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012212"},{"key":"e_1_3_4_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2012.07.034"},{"key":"e_1_3_4_80_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2402"},{"key":"e_1_3_4_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2016.06.014"},{"key":"e_1_3_4_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30772-X"},{"key":"e_1_3_4_83_2","volume-title":"Presented at the American Society of Hypertension 23rd Annual Scientific Meeting","author":"Neutel JM","unstructured":"Neutel, JM. Results of a prospective, randomized, double blind, placebo controlled study to evaluate the safety and efficacy of PS433540, a Dual Angiotensin and Endothelin Receptor Antagonist (DARA compound) in subjects with hypertension. recent and late-breaking trials. Presented at the American Society of Hypertension 23rd Annual Scientific Meeting; May 14\u201317, 2008; New Orleans."},{"key":"e_1_3_4_84_2","first-page":"478","volume-title":"In: American Society of Hypertension. 23rd Annual Scientific Meeting and Exposition \u2013 Meeting Highlights","volume":"33","author":"Neutel JM","year":"2008","unstructured":"Neutel, JM. A dual receptor antagonist (PS433540, DARA). David, RB, In: American Society of Hypertension. 23rd Annual Scientific Meeting and Exposition \u2013 Meeting Highlights. P&T; 2008;33:478\u2013479."},{"key":"e_1_3_4_85_2","volume-title":"Presented at the 24th Annual Meeting of the American Society of Hypertension","author":"Neutel JM","unstructured":"Neutel, JM, Graff, A, Samson, MB, Belder, R, Zhang, J, Kapil, RP. Neutel, JM, Graff, A, Samson, MB, Belder, R, Zhang, J, Kapil, RP. PS433540, a dual angiotensin (AT1) and endothelin (ETA) receptor antagonist (DARA) demonstrates dose-dependent blood pressure lowering effects better than irbesartan in phase IIb dose ranging study in stage1 and stage II hypertensive patients. Presented at the 24th Annual Meeting of the American Society of Hypertension; May 6-9 2009; San Francisco."},{"key":"e_1_3_4_86_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2018010091"},{"key":"e_1_3_4_87_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09387-4"},{"key":"e_1_3_4_88_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.fjc.0000166218.35168.79"},{"key":"e_1_3_4_89_2","doi-asserted-by":"publisher","DOI":"10.1529\/biophysj.107.119206"},{"key":"e_1_3_4_90_2","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-019-0482-7"},{"key":"e_1_3_4_91_2","first-page":"343756","article-title":"X-ray structures of human ETB receptor provide mechanistic insight into receptor activation and partial activation.","author":"Shihoya W","year":"2019","unstructured":"Shihoya, W, Izume, T, Inoue, A, Yamashita, K, Kadji, FMN, Hirata, K, Aoki, J, Nishizawa, T, Nureki, O. X-ray structures of human ETB receptor provide mechanistic insight into receptor activation and partial activation. bioRxiv. 2019:343756. https:\/\/doi.org\/10.1101\/343756.","journal-title":"bioRxiv"},{"key":"e_1_3_4_92_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-2340"},{"key":"e_1_3_4_93_2","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2016.1208865"},{"key":"e_1_3_4_94_2","doi-asserted-by":"publisher","DOI":"10.4161\/mabs.22696"},{"key":"e_1_3_4_95_2","doi-asserted-by":"publisher","DOI":"10.33549\/physiolres.933872"},{"key":"e_1_3_4_96_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081309"},{"key":"e_1_3_4_97_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0196-9781(97)00370-7"},{"key":"e_1_3_4_98_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0995-894"},{"key":"e_1_3_4_99_2","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0000000000001414"},{"key":"e_1_3_4_100_2","doi-asserted-by":"publisher","DOI":"10.1038\/pr.2012.134"},{"key":"e_1_3_4_101_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-010-2040-0"},{"key":"e_1_3_4_102_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40200-019-00400-7"},{"key":"e_1_3_4_103_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60381-5"},{"key":"e_1_3_4_104_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066420"},{"key":"e_1_3_4_105_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.112.201020"},{"key":"e_1_3_4_106_2","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2011.212"},{"key":"e_1_3_4_107_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.11.054"},{"key":"e_1_3_4_108_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.02.067"},{"key":"e_1_3_4_109_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.02.064"},{"key":"e_1_3_4_110_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2012.01826.x"},{"key":"e_1_3_4_111_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI2698"},{"key":"e_1_3_4_112_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90018-3"},{"key":"e_1_3_4_113_2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/5.3.355"},{"key":"e_1_3_4_114_2","doi-asserted-by":"publisher","DOI":"10.1002\/humu.23206"},{"key":"e_1_3_4_115_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1706594"},{"key":"e_1_3_4_116_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)99881-9"},{"key":"e_1_3_4_117_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.10-161612"},{"key":"e_1_3_4_118_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-011-0698-1"},{"key":"e_1_3_4_119_2","first-page":"465","article-title":"Epigenetic silencing of the endothelin-B receptor gene in non-small cell lung cancer.","volume":"34","author":"Knight LJ","year":"2009","unstructured":"Knight, LJ, Burrage, J, Bujac, SR, Haggerty, C, Graham, A, Gibson, NJ, Ellison, G, Growcott, JW, Brooks, AN, Hughes, AM, Xinarianos, G, Nikolaidis, G, Field, JK, Liloglou, T. Epigenetic silencing of the endothelin-B receptor gene in non-small cell lung cancer. Int J Oncol. 2009;34:465\u2013471.","journal-title":"Int J Oncol"},{"key":"e_1_3_4_120_2","doi-asserted-by":"publisher","DOI":"10.1159\/000113146"},{"key":"e_1_3_4_121_2","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2319"},{"key":"e_1_3_4_122_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2015.02.028"},{"key":"e_1_3_4_123_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2016.12.006"},{"key":"e_1_3_4_124_2","doi-asserted-by":"publisher","DOI":"10.33549\/physiolres.933836"},{"key":"e_1_3_4_125_2","doi-asserted-by":"publisher","DOI":"10.1111\/gbb.12428"},{"key":"e_1_3_4_126_2","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.17956.1"},{"key":"e_1_3_4_127_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.27762"},{"key":"e_1_3_4_128_2","doi-asserted-by":"publisher","DOI":"10.1186\/1746-1596-8-199"},{"key":"e_1_3_4_129_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-3496"},{"key":"e_1_3_4_130_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpedsurg.2013.10.027"},{"key":"e_1_3_4_131_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2011.04062.x"},{"key":"e_1_3_4_132_2","doi-asserted-by":"publisher","DOI":"10.1691\/ph.2017.6747"},{"key":"e_1_3_4_133_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2018.08.011"},{"key":"e_1_3_4_134_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1006367"},{"key":"e_1_3_4_135_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.06.049"},{"key":"e_1_3_4_136_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20070657"},{"key":"e_1_3_4_137_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20171773"},{"key":"e_1_3_4_138_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-114-3-213"},{"key":"e_1_3_4_139_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy881"},{"key":"e_1_3_4_140_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.109.138701"},{"key":"e_1_3_4_141_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.007863"},{"key":"e_1_3_4_142_2","doi-asserted-by":"publisher","DOI":"10.1038\/368703a0"},{"key":"e_1_3_4_143_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.115.05168"},{"key":"e_1_3_4_144_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.117.09925"},{"key":"e_1_3_4_145_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.113.01298"},{"key":"e_1_3_4_146_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2013.12.214"},{"key":"e_1_3_4_147_2","doi-asserted-by":"publisher","DOI":"10.1038\/aps.2016.138"},{"key":"e_1_3_4_148_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026994"},{"key":"e_1_3_4_149_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1997.7394"},{"key":"e_1_3_4_150_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.96.5.1593"},{"key":"e_1_3_4_151_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.74.6.1141"},{"key":"e_1_3_4_152_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118623"},{"key":"e_1_3_4_153_2","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aag0240"},{"key":"e_1_3_4_154_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2005.08.024"},{"key":"e_1_3_4_155_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2015.07.014"},{"key":"e_1_3_4_156_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000051459.74466.46"},{"key":"e_1_3_4_157_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.109.216036"},{"key":"e_1_3_4_158_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000198555.51645.f1"},{"key":"e_1_3_4_159_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0706193"},{"key":"e_1_3_4_160_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ydbio.2007.05.018"},{"key":"e_1_3_4_161_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000001599"},{"key":"e_1_3_4_162_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.24.2.183"},{"key":"e_1_3_4_163_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.25.4.495"},{"key":"e_1_3_4_164_2","doi-asserted-by":"publisher","DOI":"10.1139\/y03-009"},{"key":"e_1_3_4_165_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2005.03.004"},{"key":"e_1_3_4_166_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V115835"},{"key":"e_1_3_4_167_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0895-7061(01)02074-x"},{"key":"e_1_3_4_168_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.33.2.753"},{"key":"e_1_3_4_169_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.108.117366"},{"key":"e_1_3_4_170_2","doi-asserted-by":"publisher","DOI":"10.1159\/000487346"},{"key":"e_1_3_4_171_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199803193381202"},{"key":"e_1_3_4_172_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0895-7061(02)02933-3"},{"key":"e_1_3_4_173_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000245138.09687.8a"},{"key":"e_1_3_4_174_2","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2009.135"},{"key":"e_1_3_4_175_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-019-0176-3"},{"key":"e_1_3_4_176_2","unstructured":"Danaietash P Verweij P Flamion B Menard J Bellet M. Efficacy and safety of various doses of the new dual endothelin receptor antagonist aprocitentan in the treatment of hypertension. Presented at ESC 2019 Congress Paris August 31-September 4 2019. https:\/\/esc365.escardio.org\/Presentation\/195683 (abstract)."},{"key":"e_1_3_4_177_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.118.312156"},{"key":"e_1_3_4_178_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(18)30080-9"},{"key":"e_1_3_4_179_2","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.161486"},{"key":"e_1_3_4_180_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41371-018-0094-6"},{"key":"e_1_3_4_181_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.108.120022"},{"key":"e_1_3_4_182_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.28.4.652"},{"key":"e_1_3_4_183_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(96)00259-2"},{"key":"e_1_3_4_184_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.36.1.62"},{"issue":"1","key":"e_1_3_4_185_2","first-page":"AP116","article-title":"Induction of human endothelin-1 overexpression for 3 months Increases plasma aldosterone.","volume":"72","author":"Berillo O","year":"2018","unstructured":"Berillo, O, Coelho, SC, Mahjoub, N, Ferreira, N, Offermanns, S, Paradis, P, Schiffrin, EL. Induction of human endothelin-1 overexpression for 3 months Increases plasma aldosterone. Hypertension. 2018;72(suppl 1):AP116.","journal-title":"Hypertension"},{"key":"e_1_3_4_186_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo.138.10.5267"},{"key":"e_1_3_4_187_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.12944"},{"key":"e_1_3_4_188_2","first-page":"e430","article-title":"Refractory versus resistant hypertension: novel distinctive phenotypes.","volume":"3","author":"Dudenbostel T","year":"2017","unstructured":"Dudenbostel, T, Siddiqui, M, Gharpure, N, Calhoun, DA. Refractory versus resistant hypertension: novel distinctive phenotypes. J Nat Sci. 2017;3:e430.","journal-title":"J Nat Sci"},{"key":"e_1_3_4_189_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.37.6.1444"},{"key":"e_1_3_4_190_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000078357.92682.EC"},{"key":"e_1_3_4_191_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.31.1.499"},{"key":"e_1_3_4_192_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.30.4.905"},{"key":"e_1_3_4_193_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-6175.2007.07244.x"},{"key":"e_1_3_4_194_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61500-2"},{"key":"e_1_3_4_195_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.110.156976"},{"key":"e_1_3_4_196_2","unstructured":"GlinicalTrials.gov. A research study to show the effect of aprocitentan in the treatment of difficult to control (resistant) high blood pressure (hypertension) and find out more about its safety (PRECISION). U.S. National Library of Medicine Clinical Trials rials Nr. NCT03541174. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03541174 Accessed September 13 2019"},{"key":"e_1_3_4_197_2","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2017.1282623"},{"key":"e_1_3_4_198_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.38.3.718"},{"key":"e_1_3_4_199_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mn.7800137"},{"key":"e_1_3_4_200_2","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0000000000000197"},{"key":"e_1_3_4_201_2","doi-asserted-by":"publisher","DOI":"10.1042\/CS20190464"},{"key":"e_1_3_4_202_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67726-4"},{"key":"e_1_3_4_203_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39335.385301.BE"},{"key":"e_1_3_4_204_2","doi-asserted-by":"publisher","DOI":"10.1177\/1741826711421079"},{"key":"e_1_3_4_205_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-018-0828-4"},{"key":"e_1_3_4_206_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000001600"},{"key":"e_1_3_4_207_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.115.05267"},{"key":"e_1_3_4_208_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18030522"},{"key":"e_1_3_4_209_2","doi-asserted-by":"publisher","DOI":"10.1177\/1933719115592707"},{"key":"e_1_3_4_210_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2018.10.002"},{"key":"e_1_3_4_211_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpv099"},{"key":"e_1_3_4_212_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.182220"},{"key":"e_1_3_4_213_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e32835c1d1b"},{"key":"e_1_3_4_214_2","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.27706"},{"key":"e_1_3_4_215_2","unstructured":"ClinicalTrials.gov. Endothelial effects of VEGF inhibition in vivo in man (ENDEAVOUR). U.S. Library of Medicine Clinical Trials Nr. NCT03557190. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03557190. Accessed September 13 2019."},{"key":"e_1_3_4_216_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.110.167486"},{"key":"e_1_3_4_217_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h3764"},{"key":"e_1_3_4_218_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014040323"},{"key":"e_1_3_4_219_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00089.2011"},{"key":"e_1_3_4_220_2","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.118.310958"},{"key":"e_1_3_4_221_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)92126-e"},{"key":"e_1_3_4_222_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199110033251404"},{"key":"e_1_3_4_223_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.79.4.794"},{"key":"e_1_3_4_224_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-001-0095-6"},{"key":"e_1_3_4_225_2","doi-asserted-by":"publisher","DOI":"10.1042\/CS20100475"},{"key":"e_1_3_4_226_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-200036051-00048"},{"key":"e_1_3_4_227_2","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj-2018-136298"},{"key":"e_1_3_4_228_2","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.119.312682"},{"key":"e_1_3_4_229_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00143.2018"},{"key":"e_1_3_4_230_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-1716.2009.02062.x"},{"key":"e_1_3_4_231_2","doi-asserted-by":"publisher","DOI":"10.1160\/TH06-08-0479"},{"key":"e_1_3_4_232_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.24.14367"},{"key":"e_1_3_4_233_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-000-0064-5"},{"key":"e_1_3_4_234_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0895-7061(02)03006-6"},{"key":"e_1_3_4_235_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004424-200206000-00007"},{"key":"e_1_3_4_236_2","doi-asserted-by":"publisher","DOI":"10.1097\/CRD.0b013e318283f65a"},{"key":"e_1_3_4_237_2","doi-asserted-by":"publisher","DOI":"10.1152\/physiolgenomics.00218.2009"},{"key":"e_1_3_4_238_2","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.113.302028"},{"key":"e_1_3_4_239_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpw078"},{"key":"e_1_3_4_240_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpz069"},{"key":"e_1_3_4_241_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.12.6920"},{"key":"e_1_3_4_242_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.97.8.752"},{"key":"e_1_3_4_243_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000670"},{"key":"e_1_3_4_244_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy856"},{"key":"e_1_3_4_245_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.08.1038"},{"key":"e_1_3_4_246_2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/978-1-4615-5181-2_9","volume-title":"In: Chest Pain With Normal Coronary Angiograms: Pathogenesis, Diagnosis And Management","author":"Cox ID","year":"1999","unstructured":"Cox, ID, Kaski, JC. Endothelin: an important mediator in the pathophysiology of syndrome X? Kaski, JC, ed. In: Chest Pain With Normal Coronary Angiograms: Pathogenesis, Diagnosis And Management. Heidelberg: Springer Verlag; 1999:101\u2013114."},{"key":"e_1_3_4_247_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.101.16.1899"},{"key":"e_1_3_4_248_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2014.02.026"},{"key":"e_1_3_4_249_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-011-2415-y"},{"key":"e_1_3_4_250_2","doi-asserted-by":"publisher","DOI":"10.1139\/Y08-081"},{"key":"e_1_3_4_251_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.967406"},{"key":"e_1_3_4_252_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2014.00015"},{"key":"e_1_3_4_253_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9149(01)01441-2"},{"key":"e_1_3_4_254_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.102.16.1937"},{"key":"e_1_3_4_255_2","doi-asserted-by":"publisher","DOI":"10.1161\/hc3501.095707"},{"key":"e_1_3_4_256_2","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2016-000428"},{"key":"e_1_3_4_257_2","doi-asserted-by":"publisher","DOI":"10.2147\/vhrm.s7867"},{"key":"e_1_3_4_258_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-016-6641-x"},{"key":"e_1_3_4_259_2","volume-title":"Presented at EuroPCR","author":"Liou K","unstructured":"Liou, K, Thomas, S, Elias, G, Buckley, N, Carlyle, A, Robaei, D, Allan, M, Kushwaha, V, Jepson, N, Ooi, SY. Endothelin-1 receptor antagonism in the prevention of microvascular injury in patients with NSTE-ACS undergoing wsPCI: the ENDORA-PCI trial. Presented at EuroPCR; May 16-May 19, 2017; Paris, France."},{"key":"e_1_3_4_260_2","volume-title":"Evaluation of the Interaction Between Endothelin Antagonism, the Coronary Microcirculation, Coronary Inflammation and Cardiac Function in Patients Undergoing Percutaneous Coronary Intervention for Non-ST-Elevation Acute Coronary Syndrome. PhD Thesis, Prince of Wales Clinical School Faculty of Medicine","author":"Liou K","year":"2018","unstructured":"Liou, K. Evaluation of the Interaction Between Endothelin Antagonism, the Coronary Microcirculation, Coronary Inflammation and Cardiac Function in Patients Undergoing Percutaneous Coronary Intervention for Non-ST-Elevation Acute Coronary Syndrome. PhD Thesis, Prince of Wales Clinical School Faculty of Medicine. Australia: University of New South Wales; 2018."},{"key":"e_1_3_4_261_2","doi-asserted-by":"publisher","DOI":"10.4244\/EIJV7I12A218"},{"key":"e_1_3_4_262_2","doi-asserted-by":"publisher","DOI":"10.1160\/TH13-10-0832"},{"key":"e_1_3_4_263_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(02)02708-0"},{"key":"e_1_3_4_264_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(03)00194-3"},{"key":"e_1_3_4_265_2","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2003.156"},{"key":"e_1_3_4_266_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.108.113068"},{"key":"e_1_3_4_267_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2012.12.001"},{"key":"e_1_3_4_268_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40256-018-0307-y"},{"key":"e_1_3_4_269_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2010.02.019"},{"key":"e_1_3_4_270_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht434"},{"key":"e_1_3_4_271_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.carpath.2014.08.004"},{"key":"e_1_3_4_272_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfu361"},{"key":"e_1_3_4_273_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2013.477"},{"key":"e_1_3_4_274_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz007"},{"key":"e_1_3_4_275_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000564"},{"key":"e_1_3_4_276_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2011.11.056"},{"key":"e_1_3_4_277_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.01.085"},{"key":"e_1_3_4_278_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.012570"},{"key":"e_1_3_4_279_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.013361"},{"key":"e_1_3_4_280_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2019.02.040"},{"key":"e_1_3_4_281_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.011990"},{"key":"e_1_3_4_282_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.09.006"},{"key":"e_1_3_4_283_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.009174"},{"key":"e_1_3_4_284_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-128-4-199802150-00006"},{"key":"e_1_3_4_285_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-131-5-199909070-00019"},{"key":"e_1_3_4_286_2","doi-asserted-by":"publisher","DOI":"10.1016\/bs.apha.2016.05.003"},{"key":"e_1_3_4_287_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.98.5.385"},{"key":"e_1_3_4_288_2","doi-asserted-by":"publisher","DOI":"10.1016\/0041-0101(86)90153-4"},{"key":"e_1_3_4_289_2","doi-asserted-by":"publisher","DOI":"10.1016\/0041-0101(88)90232-2"},{"key":"e_1_3_4_290_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.09.085"},{"key":"e_1_3_4_291_2","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.12557"},{"key":"e_1_3_4_292_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.30.1.29"},{"key":"e_1_3_4_293_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002384"},{"key":"e_1_3_4_294_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.107.089706"},{"key":"e_1_3_4_295_2","doi-asserted-by":"publisher","DOI":"10.2174\/157488609789006976"},{"key":"e_1_3_4_296_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2007.08.023"},{"key":"e_1_3_4_297_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.23403"},{"key":"e_1_3_4_298_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115258"},{"key":"e_1_3_4_299_2","first-page":"993","article-title":"Valproic acid substantially downregulated genes folr1, IGF2R, RGS2, COL6A3, EDNRB, KLF6, and pax-3, N-acetylcysteine alleviated most of the induced gene alterations in chicken embryo model.","volume":"54","author":"Hsieh CL","year":"2013","unstructured":"Hsieh, CL, Chen, KC, Ding, CY, Tsai, WJ, Wu, JF, Peng, CC. Valproic acid substantially downregulated genes folr1, IGF2R, RGS2, COL6A3, EDNRB, KLF6, and pax-3, N-acetylcysteine alleviated most of the induced gene alterations in chicken embryo model. Rom J Morphol Embryol. 2013;54:993\u20131004.","journal-title":"Rom J Morphol Embryol"},{"key":"e_1_3_4_300_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197509)36:3<904::aid-cncr2820360311>3.0.co;2-u"},{"key":"e_1_3_4_301_2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.4979"},{"key":"e_1_3_4_302_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0065486"},{"key":"e_1_3_4_303_2","doi-asserted-by":"publisher","DOI":"10.1667\/RR0780.1"},{"key":"e_1_3_4_304_2","doi-asserted-by":"publisher","DOI":"10.1667\/RR1093.1"},{"key":"e_1_3_4_305_2","doi-asserted-by":"publisher","DOI":"10.4103\/0973-1482.203601"},{"key":"e_1_3_4_306_2","first-page":"56","volume-title":"In: Clinical Aspect of Myocardial Injury: From Ischemia to Heart Failure","author":"Sato H","year":"1990","unstructured":"Sato, H, Tatetishi, H, Uchida, T, Dote, K, Ishihara, M. Tako-tsubo-like left ventricular dysfunction due to multivessel coronary spasm. Kodama, K., Haze, K. Hori, M, eds. In: Clinical Aspect of Myocardial Injury: From Ischemia to Heart Failure. Tokyo: Kagakuhyoronsha Publishing Company; 1990:56\u201364."},{"key":"e_1_3_4_307_2","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2002.120403"},{"key":"e_1_3_4_308_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2017.12.009"},{"key":"e_1_3_4_309_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1406761"},{"key":"e_1_3_4_310_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.010881"},{"key":"e_1_3_4_311_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.04.117"},{"key":"e_1_3_4_312_2","doi-asserted-by":"publisher","DOI":"10.3810\/hp.2000.02.183"},{"key":"e_1_3_4_313_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht392"},{"key":"e_1_3_4_314_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e32833a4922"},{"key":"e_1_3_4_315_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy529"},{"key":"e_1_3_4_316_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.83.2.476"},{"key":"e_1_3_4_317_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(91)90484-3"},{"key":"e_1_3_4_318_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/14.6.780"},{"key":"e_1_3_4_319_2","doi-asserted-by":"publisher","DOI":"10.1097\/MCA.0b013e32832e5c8c"},{"key":"e_1_3_4_320_2","doi-asserted-by":"publisher","DOI":"10.2143\/AC.64.3.2038032"},{"key":"e_1_3_4_321_2","doi-asserted-by":"publisher","DOI":"10.1159\/000313365"},{"key":"e_1_3_4_322_2","doi-asserted-by":"publisher","DOI":"10.5543\/tkda.2013.37998"},{"key":"e_1_3_4_323_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2015.04.026"},{"key":"e_1_3_4_324_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9149(97)00439-6"},{"key":"e_1_3_4_325_2","first-page":"3","article-title":"Comparison of endothelin-1 levels at rest and during exercise between patients with cardiac syndrome-X and healthy people.","volume":"53","author":"Michelakakis NA","year":"1998","unstructured":"Michelakakis, NA, Petropoulou, EN, Lazaros, GA, Perpinia, AS, Vrachatis, AD, Apostolou, TS, Zacharoulis, AA. Comparison of endothelin-1 levels at rest and during exercise between patients with cardiac syndrome-X and healthy people. Acta Cardiol. 1998;53:3\u20136.","journal-title":"Acta Cardiol"},{"key":"e_1_3_4_326_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(99)00379-4"},{"key":"e_1_3_4_327_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.102.19.2359"},{"key":"e_1_3_4_328_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(98)00143-0"},{"key":"e_1_3_4_329_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.113.302549"},{"key":"e_1_3_4_330_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1409026111"},{"key":"e_1_3_4_331_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2014.03.005"},{"key":"e_1_3_4_332_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0008-6363(00)00263-7"},{"key":"e_1_3_4_333_2","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.53.259"},{"key":"e_1_3_4_334_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0006-291x(05)81080-0"},{"key":"e_1_3_4_335_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0008-6363(98)00018-2"},{"key":"e_1_3_4_336_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.109.924985"},{"key":"e_1_3_4_337_2","first-page":"279","article-title":"Contribution of the endothelin system to the genesis and maintenance of atrial fibrillation: review of the literature and clinical implications.","volume":"56","author":"Baltogiannis GG","year":"2015","unstructured":"Baltogiannis, GG, Kolettis, TM, Chierchia, GB, Sieira, J, di Giovanni, G, Brugada, P. Contribution of the endothelin system to the genesis and maintenance of atrial fibrillation: review of the literature and clinical implications. Hellenic J Cardiol. 2015;56:279\u2013284.","journal-title":"Hellenic J Cardiol"},{"key":"e_1_3_4_338_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8167.2007.01033.x"},{"key":"e_1_3_4_339_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0014-2999(01)01396-6"},{"key":"e_1_3_4_340_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199504000-00018"},{"key":"e_1_3_4_341_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2005.04.020"},{"key":"e_1_3_4_342_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.fjc.0000166227.03712.06"},{"key":"e_1_3_4_343_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1023961004016"},{"key":"e_1_3_4_344_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.192065"},{"key":"e_1_3_4_345_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.113.300268"},{"key":"e_1_3_4_346_2","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.140430"},{"key":"e_1_3_4_347_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.58"},{"key":"e_1_3_4_348_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(89)90303-6"},{"key":"e_1_3_4_349_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2004.01.008"},{"key":"e_1_3_4_350_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.93.6.1214"},{"key":"e_1_3_4_351_2","doi-asserted-by":"publisher","DOI":"10.1139\/y03-052"},{"key":"e_1_3_4_352_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)77807-7"},{"key":"e_1_3_4_353_2","doi-asserted-by":"publisher","DOI":"10.1016\/s1388-9842(99)00022-7"},{"key":"e_1_3_4_354_2","first-page":"I","article-title":"Multicenter, double-blind, placebo-controlled study of long-term endothelin blockade with bosentan in chronic heart failure. results of the REACH-1 trial.","volume":"98","author":"Packer M","year":"1998","unstructured":"Packer, M, Caspi, A, Charlon, V, Cohen-Solai, A, Kiowski, W, Kostuk, W, Krum, H, Levine, B, Massie, B, McMurray, J, Rizon, P, Swedberg, K. Multicenter, double-blind, placebo-controlled study of long-term endothelin blockade with bosentan in chronic heart failure. results of the REACH-1 trial. Circulation. 1998;98:I\u20133.","journal-title":"Circulation"},{"key":"e_1_3_4_355_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2017.02.021"},{"key":"e_1_3_4_356_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000038497.80095.e1"},{"key":"e_1_3_4_357_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16723-8"},{"key":"e_1_3_4_358_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2004.040386"},{"key":"e_1_3_4_359_2","first-page":"401","article-title":"for the ENCOR investigators and coordinators. Effects of enrasentan, a nonselective endothelin receptor antagonist in class II-III heart failure: results of the Enrasentan Cooperative Randomized (ENCOR) evaluation.","volume":"37","author":"Abraham WT","year":"2001","unstructured":"Abraham, WT, Ascheim, D, DeMarco, T, Klapholz, M, Kukin, M, Miller, A. for the ENCOR investigators and coordinators. Effects of enrasentan, a nonselective endothelin receptor antagonist in class II-III heart failure: results of the Enrasentan Cooperative Randomized (ENCOR) evaluation. J Am Coll Cardiol. 2001;37(suppl):401.","journal-title":"J Am Coll Cardiol"},{"key":"e_1_3_4_360_2","doi-asserted-by":"publisher","DOI":"10.1016\/s1388-9842(01)00149-0"},{"key":"e_1_3_4_361_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-8703(02)00127-8"},{"key":"e_1_3_4_362_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.298.17.2009"},{"key":"e_1_3_4_363_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00145910"},{"key":"e_1_3_4_364_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2004.049734"},{"key":"e_1_3_4_365_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2006.089250"},{"key":"e_1_3_4_366_2","first-page":"696","article-title":"Clinical trials of endothelin antagonists in heart failure: a question of dose?","volume":"231","author":"Kelland NF","year":"2006","unstructured":"Kelland, NF, Webb, DJ. Clinical trials of endothelin antagonists in heart failure: a question of dose? Exp Biol Med (Maywood). 2006;231:696\u2013699.","journal-title":"Exp Biol Med (Maywood)"},{"key":"e_1_3_4_367_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.89.4.1573"},{"key":"e_1_3_4_368_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(95)00520-x"},{"key":"e_1_3_4_369_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqx014"},{"key":"e_1_3_4_370_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2014.12.012"},{"key":"e_1_3_4_371_2","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2017.286385"},{"key":"e_1_3_4_372_2","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.456"},{"key":"e_1_3_4_373_2","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.766"},{"key":"e_1_3_4_374_2","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.550"},{"key":"e_1_3_4_375_2","first-page":"582","article-title":"Heart failure with preserved ejection fraction: diagnosis and management.","volume":"96","author":"Gazewood JD","year":"2017","unstructured":"Gazewood, JD, Turner, PL. Heart failure with preserved ejection fraction: diagnosis and management. Am Fam Physician. 2017;96:582\u2013588.","journal-title":"Am Fam Physician"},{"key":"e_1_3_4_376_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-019-09806-0"},{"key":"e_1_3_4_377_2","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.327"},{"key":"e_1_3_4_378_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2017.65"},{"key":"e_1_3_4_379_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfq121"},{"key":"e_1_3_4_380_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.010637"},{"key":"e_1_3_4_381_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1100-z"},{"key":"e_1_3_4_382_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.116.003381"},{"key":"e_1_3_4_383_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlc.2016.09.004"},{"key":"e_1_3_4_384_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2013.12.002"},{"key":"e_1_3_4_385_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j5492"},{"key":"e_1_3_4_386_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2011.03.003"},{"key":"e_1_3_4_387_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2008.12.003"},{"key":"e_1_3_4_388_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60919-8"},{"key":"e_1_3_4_389_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.742510"},{"key":"e_1_3_4_390_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.07.033"},{"key":"e_1_3_4_391_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1213917"},{"key":"e_1_3_4_392_2","doi-asserted-by":"publisher","DOI":"10.2147\/vhrm.s4713"},{"key":"e_1_3_4_393_2","doi-asserted-by":"publisher","DOI":"10.2147\/VHRM.S133921"},{"key":"e_1_3_4_394_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-016-9928-6"},{"key":"e_1_3_4_395_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.12.092"},{"key":"e_1_3_4_396_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1413687"},{"key":"e_1_3_4_397_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2015.08.080"},{"key":"e_1_3_4_398_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.008441"},{"key":"e_1_3_4_399_2","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb.11.6.7946395"},{"key":"e_1_3_4_400_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.12.083"},{"key":"e_1_3_4_401_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.630715"},{"key":"e_1_3_4_402_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.037171"},{"key":"e_1_3_4_403_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.883876"},{"key":"e_1_3_4_404_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.033575"},{"key":"e_1_3_4_405_2","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(11)70189-2"},{"key":"e_1_3_4_406_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(17)30433-2"},{"key":"e_1_3_4_407_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-019-00766-0"},{"key":"e_1_3_4_408_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.156.2.9607123"},{"key":"e_1_3_4_409_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201011-1874OC"},{"key":"e_1_3_4_410_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200705-732OC"},{"key":"e_1_3_4_411_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201403-0446OC"},{"key":"e_1_3_4_412_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-9-201305070-00003"},{"key":"e_1_3_4_413_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.143"},{"key":"e_1_3_4_414_2","doi-asserted-by":"publisher","DOI":"10.1002\/cphy.c100039"},{"key":"e_1_3_4_415_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.47.120505.105134"},{"key":"e_1_3_4_416_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119297"},{"key":"e_1_3_4_417_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI75079"},{"key":"e_1_3_4_418_2","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0b013e328335f91f"},{"key":"e_1_3_4_419_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2015.02.005"},{"key":"e_1_3_4_420_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00040.2019"},{"key":"e_1_3_4_421_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.12919"},{"key":"e_1_3_4_422_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200161060-00003"},{"key":"e_1_3_4_423_2","doi-asserted-by":"publisher","DOI":"10.1517\/14728214.10.4.747"},{"key":"e_1_3_4_424_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.17.4.263"},{"key":"e_1_3_4_425_2","doi-asserted-by":"publisher","DOI":"10.1067\/mlc.2000.105972"},{"key":"e_1_3_4_426_2","doi-asserted-by":"publisher","DOI":"10.1067\/mlc.2000.105616"},{"key":"e_1_3_4_427_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncpneph0891"},{"key":"e_1_3_4_428_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013020195"},{"key":"e_1_3_4_429_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014020174"},{"key":"e_1_3_4_430_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00340.2009"},{"key":"e_1_3_4_431_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-009-1540-3"},{"key":"e_1_3_4_432_2","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12064"},{"key":"e_1_3_4_433_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006030208"},{"key":"e_1_3_4_434_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00182.2018"},{"key":"e_1_3_4_435_2","doi-asserted-by":"publisher","DOI":"10.2337\/db15-1413"},{"key":"e_1_3_4_436_2","first-page":"89","volume-title":"In: Regulation of Vascular Tone in Humans by Endothelium-derived Mediators [PhD thesis]","author":"Honing ML","year":"2000","unstructured":"Honing, ML, Bouter, PK, Ballard, DE, Padley, P, Morrison, PJ, Rabelink, TJ. ABT-627, a selective ETA-receptor anatagonist, reduces proteinuria in patients with diabetes mellitus. In: Regulation of Vascular Tone in Humans by Endothelium-derived Mediators [PhD thesis]. Utrecht, The Netherlands: Elinkwijk BV; 2000:89\u2013102."},{"key":"e_1_3_4_437_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2008050482"},{"key":"e_1_3_4_438_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2009060593"},{"key":"e_1_3_4_439_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-13-166"},{"key":"e_1_3_4_440_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00060.2009"},{"key":"e_1_3_4_441_2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00570115"},{"key":"e_1_3_4_442_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013080830"},{"key":"e_1_3_4_443_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2017.07.011"},{"key":"e_1_3_4_444_2","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13315"},{"key":"e_1_3_4_445_2","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13245"},{"key":"e_1_3_4_446_2","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13312"},{"key":"e_1_3_4_447_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-006-9014-7"},{"key":"e_1_3_4_448_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-7091-1192-5_7"},{"key":"e_1_3_4_449_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2015-0139"},{"key":"e_1_3_4_450_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0535-y"},{"key":"e_1_3_4_451_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1997.28"},{"key":"e_1_3_4_452_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2010.03.012"},{"key":"e_1_3_4_453_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-010-0860-y"},{"key":"e_1_3_4_454_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000149249.09147.b4"},{"key":"e_1_3_4_455_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2015091070"},{"key":"e_1_3_4_456_2","doi-asserted-by":"publisher","DOI":"10.1159\/000444719"},{"key":"e_1_3_4_457_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013040362"},{"key":"e_1_3_4_458_2","doi-asserted-by":"publisher","DOI":"10.1159\/000328692"},{"key":"e_1_3_4_459_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI71195"},{"key":"e_1_3_4_460_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2019.05.007"},{"key":"e_1_3_4_461_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfk004"},{"key":"e_1_3_4_462_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00453.2004"},{"key":"e_1_3_4_463_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.37.2.490"},{"key":"e_1_3_4_464_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.104.528984"},{"key":"e_1_3_4_465_2","unstructured":"ClinicalTrials.gov. Study of sparsentan in patients with primary focal segmental glomerulosclerosis (FSGS) (DUPLEX). U.S. Library of Medicine Clinical Trials Nr. NCT03493685. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03493685. Accessed September 13 2019."},{"key":"e_1_3_4_466_2","doi-asserted-by":"publisher","DOI":"10.1067\/mva.2002.127351"},{"key":"e_1_3_4_467_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118102"},{"key":"e_1_3_4_468_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfi111"},{"key":"e_1_3_4_469_2","doi-asserted-by":"publisher","DOI":"10.1111\/apha.12397"},{"key":"e_1_3_4_470_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.156869"},{"key":"e_1_3_4_471_2","doi-asserted-by":"publisher","DOI":"10.1042\/CS20190215"},{"key":"e_1_3_4_472_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI33308"},{"key":"e_1_3_4_473_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016070711"},{"key":"e_1_3_4_474_2","unstructured":"ClinicalTrials.gov. The role of endothelin-1 in sickle cell disease. U.S. Library of Medicine Clinical Trials Nr. NCT02712346. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02712346. Accessed September 13 2019."},{"key":"e_1_3_4_475_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2016.02.018"},{"key":"e_1_3_4_476_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.heares.2016.08.003"},{"key":"e_1_3_4_477_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00532.2015"},{"key":"e_1_3_4_478_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3546"},{"key":"e_1_3_4_479_2","first-page":"3465","article-title":"Endothelin-A receptor antagonists in prostate cancer treatment-a meta-analysis.","volume":"8","author":"Qiao L","year":"2015","unstructured":"Qiao, L, Liang, Y, Li, N, Hu, X, Luo, D, Gu, J, Lu, Y, Zheng, Q. Endothelin-A receptor antagonists in prostate cancer treatment-a meta-analysis. Int J Clin Exp Med. 2015;8:3465\u20133473.","journal-title":"Int J Clin Exp Med"},{"key":"e_1_3_4_480_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.27674"},{"key":"e_1_3_4_481_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22996"},{"key":"e_1_3_4_482_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23864"},{"key":"e_1_3_4_483_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.23.9529"},{"key":"e_1_3_4_484_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31559-9"},{"key":"e_1_3_4_485_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2006.11.016"},{"key":"e_1_3_4_486_2","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201607156"},{"key":"e_1_3_4_487_2","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-9-69"},{"key":"e_1_3_4_488_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-13-0446"},{"key":"e_1_3_4_489_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-019-00832-1"},{"key":"e_1_3_4_490_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14771"},{"key":"e_1_3_4_491_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073332"},{"key":"e_1_3_4_492_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4012-7"},{"key":"e_1_3_4_493_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-005-9111-z"},{"key":"e_1_3_4_494_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-3195"},{"key":"e_1_3_4_495_2","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2017.121"},{"key":"e_1_3_4_496_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-018-0100-8"},{"key":"e_1_3_4_497_2","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/now037"},{"key":"e_1_3_4_498_2","doi-asserted-by":"publisher","DOI":"10.1593\/neo.10806"},{"key":"e_1_3_4_499_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11045-8"},{"key":"e_1_3_4_500_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1295430"},{"key":"e_1_3_4_501_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2017.160"},{"key":"e_1_3_4_502_2","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.8.20.9595"},{"key":"e_1_3_4_503_2","doi-asserted-by":"publisher","DOI":"10.2174\/157489006778776990"},{"key":"e_1_3_4_504_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.04.012"},{"key":"e_1_3_4_505_2","doi-asserted-by":"publisher","DOI":"10.1161\/hq0202.103994"},{"key":"e_1_3_4_506_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature03085"},{"key":"e_1_3_4_507_2","doi-asserted-by":"publisher","DOI":"10.1002\/pros.23284"},{"key":"e_1_3_4_508_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2018.06.009"},{"key":"e_1_3_4_509_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.135772"},{"key":"e_1_3_4_510_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.39212"},{"key":"e_1_3_4_511_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-015-0505-4"},{"key":"e_1_3_4_512_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2016.03.005"},{"key":"e_1_3_4_513_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2017.134"},{"key":"e_1_3_4_514_2","doi-asserted-by":"publisher","DOI":"10.1186\/ar2186"},{"key":"e_1_3_4_515_2","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/201787"},{"key":"e_1_3_4_516_2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209909"},{"key":"e_1_3_4_517_2","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150061"},{"key":"e_1_3_4_518_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201403-0442OC"},{"key":"e_1_3_4_519_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.20676"},{"key":"e_1_3_4_520_2","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2013-203174"},{"key":"e_1_3_4_521_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.130658"},{"key":"e_1_3_4_522_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.5258"},{"key":"e_1_3_4_523_2","first-page":"1065","article-title":"Up-regulation of endothelin-1 mRNA and peptide expression in rat cardiac allografts with rejection and arteriosclerosis.","volume":"146","author":"Watschinger B","year":"1995","unstructured":"Watschinger, B, Sayegh, MH, Hancock, WW, Russell, ME. Up-regulation of endothelin-1 mRNA and peptide expression in rat cardiac allografts with rejection and arteriosclerosis. Am J Pathol. 1995;146:1065\u20131072.","journal-title":"Am J Pathol"},{"key":"e_1_3_4_524_2","first-page":"86","article-title":"Pattern of endothelin immunostaining during rejection episodes after kidney transplantation.","volume":"41","author":"Watschinger B","year":"1994","unstructured":"Watschinger, B, Vychytil, A, Attar, M, Wagner, D, Schuller, M, Hartter, E, Ulrich, W. Pattern of endothelin immunostaining during rejection episodes after kidney transplantation. Clin Nephrol. 1994;41:86\u201393.","journal-title":"Clin Nephrol"},{"key":"e_1_3_4_525_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000015606.69079.27"},{"key":"e_1_3_4_526_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2018.05.001"},{"key":"e_1_3_4_527_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2018.12.001"},{"key":"e_1_3_4_528_2","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14053"},{"key":"e_1_3_4_529_2","doi-asserted-by":"publisher","DOI":"10.1097\/MOT.0b013e3283636e55"},{"key":"e_1_3_4_530_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2016.03.019"},{"key":"e_1_3_4_531_2","first-page":"31","article-title":"The clinical impact of non-HLA antibodies in solid organ transplantation.","volume":"32","author":"Freischlag K","year":"2016","unstructured":"Freischlag, K, Pearl, MH, Chambers, ET. The clinical impact of non-HLA antibodies in solid organ transplantation. Clin Transpl. 2016;32:31\u201343.","journal-title":"Clin Transpl"},{"key":"e_1_3_4_532_2","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3182692ad2"},{"key":"e_1_3_4_533_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2013.10.007"},{"key":"e_1_3_4_534_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(95)00094-g"},{"key":"e_1_3_4_535_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0041-1345(98)01983-6"},{"key":"e_1_3_4_536_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199901270-00025"},{"key":"e_1_3_4_537_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V102387"},{"key":"e_1_3_4_538_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/18.1.62"},{"key":"e_1_3_4_539_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.157.6.9709131"},{"key":"e_1_3_4_540_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199909270-00005"},{"key":"e_1_3_4_541_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2003.06.018"},{"key":"e_1_3_4_542_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0041-1345(98)01241-x"},{"key":"e_1_3_4_543_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004150050360"},{"key":"e_1_3_4_544_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0041-1345(97)01452-8"},{"key":"e_1_3_4_545_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.1991.261.6.H1791"},{"key":"e_1_3_4_546_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0012.2005.00357.x"},{"key":"e_1_3_4_547_2","doi-asserted-by":"publisher","DOI":"10.4236\/health.2014.619294"},{"key":"e_1_3_4_548_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2005.00807.x"},{"key":"e_1_3_4_549_2","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e31825f0fbe"},{"key":"e_1_3_4_550_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2018.10.001"},{"key":"e_1_3_4_551_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(91)90252-7"},{"key":"e_1_3_4_552_2","first-page":"1146","article-title":"Endothelin-1 causes pruritus in mice.","volume":"231","author":"Trentin PG","year":"2006","unstructured":"Trentin, PG, Fernandes, MB, D\u2019Orl\u00e9ans-Juste, P, Rae, GA. Endothelin-1 causes pruritus in mice. Exp Biol Med (Maywood). 2006;231:1146\u20131151.","journal-title":"Exp Biol Med (Maywood)"},{"key":"e_1_3_4_553_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(95)00178-6"},{"key":"e_1_3_4_554_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0014-2999(98)00281-7"},{"key":"e_1_3_4_555_2","first-page":"1152","article-title":"Involvement of endothelin in morphine tolerance in neuroblastoma (SH-SY5Y) cells.","volume":"231","author":"Bhalla S","year":"2006","unstructured":"Bhalla, S, Ciaccio, N, Wang, ZJ, Gulati, A. Involvement of endothelin in morphine tolerance in neuroblastoma (SH-SY5Y) cells. Exp Biol Med (Maywood). 2006;231:1152\u20131156.","journal-title":"Exp Biol Med (Maywood)"},{"key":"e_1_3_4_556_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2009.10.011"},{"key":"e_1_3_4_557_2","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000002139"},{"key":"e_1_3_4_558_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2017.10.045"},{"key":"e_1_3_4_559_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.archoralbio.2018.10.038"},{"key":"e_1_3_4_560_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2017.e00317"},{"key":"e_1_3_4_561_2","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000056"},{"key":"e_1_3_4_562_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(11)70108-9"},{"key":"e_1_3_4_563_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.111.648980"},{"key":"e_1_3_4_564_2","doi-asserted-by":"publisher","DOI":"10.1159\/000475824"},{"key":"e_1_3_4_565_2","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000000432"},{"key":"e_1_3_4_566_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.119.025682"},{"key":"e_1_3_4_567_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2202-8-7"},{"key":"e_1_3_4_568_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2007.106.5.881"},{"key":"e_1_3_4_569_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00221-006-0753-7"},{"key":"e_1_3_4_570_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2011.08.075"},{"key":"e_1_3_4_571_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2013.07.002"},{"key":"e_1_3_4_572_2","unstructured":"ClinicalTrials.gov. A prospective multi-centric randomized double blind parallel saline controlled Phase II clinical study to compare the safety and efficacy of PMZ-1620 (sovateltide) therapy along with standard supportive care in patients with acute ischemic stroke. U.S. Library of Medicine Clinical Trials Nr. NCT04046484. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04046484. Accessed September 13 2019."},{"key":"e_1_3_4_573_2","volume-title":"Late-breaking poster presented at International Stroke Conference 2019. Session \u201cOngoing clinical trials posters II (Poster CTP27),\u201d AHA International Stroke Conference 2019","author":"Gulati A","year":"2019","unstructured":"Gulati, A, Agrawal, NR, Vibha, D, Misra, UK, Paul, BS, Kumar, R, Pandian, J, Lavhale, MS. Efficacy of PMZ-1620 (IRL-1620), an endothelin-B agonist, in patients with cerebral ischemic stroke. Late-breaking poster presented at International Stroke Conference 2019. Session \u201cOngoing clinical trials posters II (Poster CTP27),\u201d AHA International Stroke Conference 2019; February 6-February 8, 2019; Honolulu, Hawaii."},{"key":"e_1_3_4_574_2","unstructured":"ClinicalTrials.gov. A prospective multicentric randomized double-blind parallel Phase AQ48 III clinical study to assess efficacy of PMZ-1620 (sovateltide) along with standard treatment in patients of acute ischemic stroke. U.S. Library of Medicine Clinical Trials Nr. NCT04047563. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04047563. Accessed September 13 2019."},{"key":"e_1_3_4_575_2","first-page":"S13","article-title":"Special characteristics of atherosclerosis in chronic renal failure.","volume":"60","author":"Amann K","year":"2003","unstructured":"Amann, K, Tyralla, K, Gross, ML, Eifert, T, Adamczak, M, Ritz, E. Special characteristics of atherosclerosis in chronic renal failure. Clin Nephrol. 2003;60(suppl 1):S13\u2013S21.","journal-title":"Clin Nephrol"},{"key":"e_1_3_4_576_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201801319R"},{"key":"e_1_3_4_577_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2016.08.011"},{"key":"e_1_3_4_578_2","doi-asserted-by":"publisher","DOI":"10.3233\/jad-2012-129043"},{"key":"e_1_3_4_579_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-183X.2007.00365.x"},{"key":"e_1_3_4_580_2","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2010-101245"},{"key":"e_1_3_4_581_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2015.05.044"},{"key":"e_1_3_4_582_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.31.6.1305"},{"key":"e_1_3_4_583_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI31547"},{"key":"e_1_3_4_584_2","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-130383"},{"key":"e_1_3_4_585_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aav9518"},{"key":"e_1_3_4_586_2","first-page":"eaav9518","article-title":"Potential role for Nox1 for endothelin-induced brain capillary vasoconstriction in Alzheimer\u2019s disease and dementia.","volume":"365","author":"Barton M","year":"2019","unstructured":"Barton, M, Meyer, MR, Prossnitz, ER. Potential role for Nox1 for endothelin-induced brain capillary vasoconstriction in Alzheimer\u2019s disease and dementia. Science. 2019;365:eaav9518 (e-letter).","journal-title":"Science"},{"key":"e_1_3_4_587_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510x(94)90057-4"},{"key":"e_1_3_4_588_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awv025"},{"key":"e_1_3_4_589_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2990.2010.01084.x"},{"key":"e_1_3_4_590_2","doi-asserted-by":"publisher","DOI":"10.4196\/kjpp.2014.18.3.201"},{"key":"e_1_3_4_591_2","doi-asserted-by":"publisher","DOI":"10.2174\/1567202613666160518122534"},{"key":"e_1_3_4_592_2","doi-asserted-by":"publisher","DOI":"10.1097\/00041327-200103000-00011"},{"key":"e_1_3_4_593_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2017.11.008"},{"key":"e_1_3_4_594_2","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/9797021"},{"key":"e_1_3_4_595_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.118.256016"},{"key":"e_1_3_4_596_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awt024"},{"key":"e_1_3_4_597_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.11.002"},{"key":"e_1_3_4_598_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2004.046755"},{"key":"e_1_3_4_599_2","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2678017"},{"key":"e_1_3_4_600_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-014-9979-8"},{"key":"e_1_3_4_601_2","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S155551"},{"key":"e_1_3_4_602_2","doi-asserted-by":"publisher","DOI":"10.2174\/156720206776875867"},{"key":"e_1_3_4_603_2","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.20383"},{"key":"e_1_3_4_604_2","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0000000000001254"},{"key":"e_1_3_4_605_2","doi-asserted-by":"publisher","DOI":"10.4103\/2008-322X.163765"},{"key":"e_1_3_4_606_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2011.01.033"},{"key":"e_1_3_4_607_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2017.04.004"},{"key":"e_1_3_4_608_2","doi-asserted-by":"publisher","DOI":"10.5414\/cpp44668"},{"key":"e_1_3_4_609_2","unstructured":"ClinicalTrials.gov. A multicenter single-arm study of the effects of atrasentan on spermatogenesis and testicular function. U.S. National Library of Medicine Clinical Trials Nr. NCT02118714. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02118714 Accessed September 13 2019."},{"key":"e_1_3_4_610_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2013.12.179"},{"key":"e_1_3_4_611_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00193308"},{"key":"e_1_3_4_612_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00058409"},{"key":"e_1_3_4_613_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00091610"},{"key":"e_1_3_4_614_2","doi-asserted-by":"publisher","DOI":"10.1042\/CS20160407"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.119.12105","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T09:59:09Z","timestamp":1715594349000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.119.12105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":613,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.119.12105"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.119.12105","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"2019-05-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-10","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}